131 related articles for article (PubMed ID: 21518134)
1. Correlation between immunocytochemistry of human papilloma virus L1 capsid protein and behavior of low-grade cervical cytology in Korean women.
Lee SJ; Lee AW; Kim TJ; Kim JH; Bae JH; Lee CW; Song MJ; Yoon JH; Hur SY; Park JS
J Obstet Gynaecol Res; 2011 Sep; 37(9):1222-8. PubMed ID: 21518134
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological implications of human papilloma virus (HPV) L1 capsid protein immunoreactivity in HPV16-positive cervical cytology.
Lee SJ; Lee AW; Kang CS; Park JS; Park DC; Ki EY; Lee KH; Yoon JH; Hur SY; Kim TJ
Int J Med Sci; 2014; 11(1):80-6. PubMed ID: 24396289
[TBL] [Abstract][Full Text] [Related]
3. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
[No Abstract] [Full Text] [Related]
4. Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management.
Yemelyanova A; Gravitt PE; Ronnett BM; Rositch AF; Ogurtsova A; Seidman J; Roden RB
Mod Pathol; 2013 Feb; 26(2):268-74. PubMed ID: 22996373
[TBL] [Abstract][Full Text] [Related]
5. High-risk HPV L1 capsid protein as a marker of cervical intraepithelial neoplasia in high-risk HPV-positive women with minor cytological abnormalities.
Norman I; Hjerpe A; Andersson S
Oncol Rep; 2013 Aug; 30(2):695-700. PubMed ID: 23756570
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of HPV L1 capsid protein detection in cervical exfoliated cells in high-risk HPV positive women].
Wang J; Tian Q; Zhang S; Lyu L; Dong J; Lyu W
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):253-7. PubMed ID: 26080935
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus DNA, HPV L1 capsid protein and p16
Hu H; Zhao J; Yu W; Zhao J; Wang Z; Jin L; Yu Y; Han L; Wang L; Zhu H; Li F
Arch Gynecol Obstet; 2019 Jan; 299(1):141-149. PubMed ID: 30390110
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical analysis of human papillomavirus L1 capsid protein in liquid-based cytology samples from cervical lesions.
Xiao W; Bian M; Ma L; Liu J; Chen Y; Yang B; Wu Q
Acta Cytol; 2010; 54(5):661-7. PubMed ID: 20968152
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
Cao L; Sun PL; Yao M; Chen S; Gao H
Hum Pathol; 2017 Jul; 65():194-200. PubMed ID: 28554573
[TBL] [Abstract][Full Text] [Related]
10. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.
Byun SW; Lee A; Kim S; Choi YJ; Lee YS; Park JS
Int J Med Sci; 2013; 10(12):1602-7. PubMed ID: 24151431
[TBL] [Abstract][Full Text] [Related]
11. [Semi-quantitative detection of HPV L1 capsid protein in exfoliative cytological examination facilitates the differential diagnosis of cervical lesions].
Xu X; Yang J; Lin N; Yang G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Nov; 30(11):1194-7. PubMed ID: 25374086
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical assessment of p16 and HPV L1 capsid protein in cervical squamous intraepithelial lesions.
Balan R; Giuşcă S; Căruntu ID; Gheorghiţă V; Neacşu D; Amălinei C
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1118-24. PubMed ID: 21495457
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
[TBL] [Abstract][Full Text] [Related]
14. [Detection of human papillomavirus L1 capsid protein expression in liquid-based cytology samples with abnormal cytology.].
Xiao W; Bian ML; Ma L; Liu J; Chen Y
Zhonghua Fu Chan Ke Za Zhi; 2009 Dec; 44(12):887-91. PubMed ID: 20193413
[TBL] [Abstract][Full Text] [Related]
15. HPV L1 capsid protein expression in squamous intraepithelial lesions of cervix uteri and its relevance to disease outcome.
Sarmadi S; Izadi-mood N; Pourlashkari M; Yarandi F; Sanii S
Arch Gynecol Obstet; 2012 Mar; 285(3):779-84. PubMed ID: 21789516
[TBL] [Abstract][Full Text] [Related]
16. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
[TBL] [Abstract][Full Text] [Related]
17. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
[TBL] [Abstract][Full Text] [Related]
18. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
19. HPV RNA in situ hybridization can inform cervical cytology-histology correlation.
Coppock JD; Willis BC; Stoler MH; Mills AM
Cancer Cytopathol; 2018 Aug; 126(8):533-540. PubMed ID: 29975461
[TBL] [Abstract][Full Text] [Related]
20. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S
Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
